Dr. Rui Wang is an Associate Professor of Population Medicine and Director of the Division of Biostatistics in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute. She is also an Associate Professor in the Department of Biostatistics at Harvard T.H. Chan School of Public Health. Dr. Wang received her PhD Degree from Harvard University.
The CDC Prevention Epicenters Program unites academic healthcare experts across the United States with the goal of enhancing public health knowledge and improving healthcare quality through innovative research focusing
The TIDE group leads several programs based on public-private partnerships between academic centers, health care organizations, and the traditional public health community focusing on the identification and reporting of notifiable infectious diseases.
Please click on the links below to learn more about our recent Infectious Disease Epidemiology Research
PopMedNet Home | How it Works | Complementary Tools | FAQs |
Sentinel is an active surveillance system sponsored by the U.S.
| Sessions | Presenter | Highlighted title below link to posted presentations; To request copies of presentations not highlighted, email:samantha_salvucci@hphc.org |
|
Welcome
UHC & medicines
|
Dr. Anita K.
MedIC Initiative TrainingThe Medicines and Insurance Coverage (MedIC) Initiative is a unique partnership between academics, health care delivery systems, health care financing institutions, and international organizations. We seek to improve population health through evidence-informed medicines policies and programs in health systems, with a particular focus on emerging and expanding insurance schemes in low and middle-income countries (LMIC) working toward universal health coverage. MedIC Activities Medicines as a Key Component of Universal Health Coverage: World Café ConversationsBackground Medicines are central to achieving the health care access, quality, and risk protection goals of universal health coverage (UHC). Wise medicines management and sound policies are also crucial for the financial sustainability of UHC schemes. Countries and schemes pursuing UHC are at different stages of developing and implementing targeted medicines management and policy approaches. Stakeholders can benefit from and are interested in sharing strategies, tools, and experiences. Assessing Medicines PricesMeasuring Medicines Prices Impacts of HPI on US Health PoliciesHPI faculty have established a strong record of national and international leadership in the evaluation of health policy changes in chronically ill populations, particularly insurance coverage for medications, use of essential medication, affordability of medication, and clinical outcomes. These studies, combined with HPI faculty testimony, advice, and major op-eds have had substantial impacts on worldwide healthcare policies in both the public and private sectors. Effects of drug reimbursement limits in Medicaid |